Accuracy Coverage Pricing Contact
Vectura plc

Vectura (VEC)

Vectura’s portfolio has emerged from the Company’s product development, formulation and drug delivery expertise and is currently centred around developing inhaled products to address unmet needs in airways diseases.

We continue to focus on balancing the unmet needs of all stakeholders (patients, physicians, payors) with commercial attractiveness and exploiting valuable niches in our therapeutic space.

Fundamentals

Optimized Dividends

Annual Dividends

Year Amount Change
2006 0.0p
2007 0.0p 0%
2008 0.0p 0%
2009 0.0p 0%
2010 0.0p 0%
2011 0.0p 0%
2012 0.0p 0%
2013 0.0p 0%
2014 0.0p 0%
2015 0.0p 0%
2016 0.0p 0%
2017 0.0p 0%
2018 0.0p 0%
2019 Login required

Dividends

Ex-Div Date Pay Date Year Type Frequency Status Amount

Recent news articles

Investment Tools Limited

The Vectura Board has announced a proposed special dividend of approximately £40m to be accompanied by a share consolidation, both subject to shareholder approval, with a £10m on-market share buyback to commence following the share consolidation. The Board also intends to undertake a further on-market £10m buyback, to be announced in due course after the completion of the first tranche.

Read more
Investment Tools Limited

Revenue up 76.0% to £126.5m (2015/16: £72.0m) 

Read more
Investment Tools Limited

Financial Highlights

Read more
Investment Tools Limited

Financial Highlights

Read more

Vectura optimized dividend - 12 month history

Optimized dividend graph demo

Vectura share price - 12 month history

You're currently viewing outdated and/or artificial data.

Try the real thing now:

Activate Free Trial